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Abstract
Streptococcus pneumoniae (pneumococci) is a leading cause of severe bacterial meningitis
in many countries worldwide. To characterize the repertoire of fitness and virulence factors
predominantly expressed during meningitis we performed niche-specific analysis of the in
vivo proteome in a mouse meningitis model, in which bacteria are directly inoculated into the
cerebrospinal fluid (CSF) cisterna magna. We generated a comprehensive mass spectrome-
try (MS) spectra library enabling bacterial proteome analysis even in the presence of eukary-
otic proteins. We recovered 200,000 pneumococci from CSF obtained from meningitis mice
and by MS we identified 685 pneumococci proteins in samples from in vitro filter controls and
249 in CSF isolates. Strikingly, the regulatory two-component system ComDE and substrate-
binding protein AliB of the oligopeptide transporter system were exclusively detected in pneu-
mococci recovered from the CSF. In the mouse meningitis model, AliB-, ComDE-, or AliB-
ComDE-deficiency resulted in attenuated meningeal inflammation and disease severity
when compared to wild-type pneumococci indicating the crucial role of ComDE and AliB in
pneumococcal meningitis. In conclusion, we show here mechanisms of pneumococcal adap-
tation to a defined host compartment by a proteome-based approach. Further, this study pro-
vides the basis of a promising strategy for the identification of protein antigens critical for
invasive disease caused by pneumococci and other meningeal pathogens.
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Author summary
Pneumococci are one of the most common and aggressive meningitis pathogens associ-
ated with mortality rates between 10% and 30%. Due to severe complications during ther-
apeutic intervention, prevention strategies to combat pneumococcal meningitis (PM) are
preferred. The vaccines available are so far suboptimal and inefficient to prevent serious
PM. Hence, deciphering the mechanisms employed by pneumococci to encounter and
survive in the cerebrospinal fluid (CSF) will pave the way for the development of new anti-
microbial strategies. This work used an in vivo proteome-based approach to identify
pneumococcal proteins expressed in the CSF during acute meningitis. This strategy iden-
tified a nutrient uptake system and regulatory system to be highly expressed in the CSF
and being crucial for PM. Knocking out two of the highly in vivo expressed proteins (AliA
and ComDE) in S. pneumoniae yields to a significant increase in survival and decrease in
pathogen burden of infected mice. These host compartment specific expressed pneumo-
coccal antigens represent promising candidates for antimicrobials or protein-based
vaccines.
Introduction
Bacterial meningitis accounts for approximately 0.5% of all deaths worldwide [1] and this cata-
pults bacterial meningitis into the list of the top ten infectious burdens around the world [2].
Streptococcus pneumoniae (the pneumococcus) is one of the most common and most
aggressive pathogen causing meningitis. The unfavourable outcome of pneumococcal menin-
gitis (PM) with mortality rates of 10 to 30% is mainly due to meningitis-related brain damage
[3, 4]. This damage is caused by both the massive inflammatory reaction and bacterial toxins
[5]. The corresponding tremendous immune response is mainly induced by bacterial cell wall
components like peptidoglycan (PGN) and lipoteichoic acid (LTA). In addition, it is known
that the proteinaceous toxin pneumolysin (Ply) produced by pneumococci is a crucial bacterial
factor implicated in meningitis-related brain damage [6–9].
However, the inflammatory response, brain damage, and clinical course can vary between
different pneumococcal serotypes, which are all positive for PGN, LTA, and Ply [10]. This
observation makes it highly conceivable that additional, yet unidentified bacterial factors con-
tribute to bacterial fitness in CSF and regulation of meningeal inflammation and/or the dam-
age of the brain, and thus to the clinical outcome of the disease.
However, little is known about the pneumococcal fitness factors and virulence determi-
nants required for crossing the blood-brain-barrier and survival within the CNS. PspC (also
known as CbpA), Ply, PavA, and neuraminidase A (NanA) are so far the best-studied virulence
factors contributing to the development of meningitis [7, 11–13]. A recent study identified
PspC and the pilus adhesin RrgA as mediators of pneumococcal brain invasion by their inter-
action with the polymeric Ig receptor and PECAM-1 [14]. Nevertheless, PspC-, Ply-, or NanA-
deficiency had no substantial impact on the disease course in an experimental model of pneu-
mococcal meningitis, suggesting that additional microbial fitness or virulence factors make an
important contribution.
Pneumococci have evolved various successful strategies to infect humans, to adapt to differ-
ent host niches, and to evade host innate immune attack mechanisms [15–17]. Identification
of the genes and proteins that are specifically required for each stage of the infection process
will enable a new level of understanding of the mechanisms employed by pathogens to circum-
vent the host defence mechanisms and cause disease. Several strategies have been employed to
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screen in vivo–induced genes, and the adaptation of pneumococci to different host milieus
including nasopharynx and blood has been correlated with a differential gene expression of
several virulence determinants [18–24]. Although proteins are the functional key players in
bacterial infection processes, a comprehensive analysis of the proteome signatures of pneumo-
cocci under infection-related has not been performed yet. Those signatures will allow gaining
insights into the adaptation and physiology of the pathogenic bacteria during colonization and
dissemination in humans. Up to now, just a few in vivo protein-profiling approaches have
been applied for S. pneumoniae, which is due to limitations in mass spectrometry (MS) sensi-
tivity and sample complexity in natural host pathogen interactions. However, in the past
decade new MS instruments and methods to isolate the pathogen from its host enables moni-
toring of changes of the proteome during infection as already shown for Staphylococcus aureus
[25].
Hence, the main focus of this study was to identify protein factors involved in the patho-
physiology of pneumococcal meningitis in order to provide a better understanding of the
underlying molecular mechanisms of the disease. We hypothesized that microbial factors that
are specifically upregulated during pneumococcal growth in the cisterna of the brain play a
crucial role in pneumococcal meningitis. To test this, we conducted a proteomic analysis of
bacteria harvested before and 18 hours after infection from the CSF of mice. We further exam-
ined the role of two selected up-regulated proteins in the disease course and investigated the
impact of the absence of these proteins by in vitro proteomics.
Results
A SpectraST library for Streptococcus pneumoniae
The interference of different peptides within a complex mixture as represented by host-patho-
gen samples from infection settings is a critical step in the analysis of tandem-MS spectra. In
most commonly applied data-analysis pipelines in silico driven putative sequences are used to
identify tandem-MS spectra. However, false-discovery rate (FDR)-based identifications of
these spectra are strongly depending on the ratio of naturally existing entries and in silico
based entries. Hence, the FDR is more error-prone in case of mixed host-pathogen samples
where two organisms are combined. One of the most suitable methods to bypass this limitation
is the so-called spectra-to-spectra search [26]. Here the number of database entries is signifi-
cantly reduced. As a prerequisite for such approaches a suitable number of tandem-MS refer-
ence spectra is necessary. High quality tandem-MS spectra from S. pneumoniae in public
repositories such as Pride [27] or PeptideAtlas [28] were not available, hence, we first estab-
lished a comprehensive consensus pneumococcal SpectraST library (Fig 1) [29]. We have con-
ducted 36 measurements from 10 different conditions mimicking the physiology and natural
in vivo milieus of S. pneumoniae (S6 Table).
Our combined analyses finally resulted in 1,165 unique protein identifications (IDs) of
which 954 were further ranked above a peptide prophet threshold of 0.95 for SpectraST library
construction. This correlates to approximately 70% of the annotated and categorized prote-
ome. These proteins were represented by 49,083 tandem-MS spectra reflecting in total 7,597
unique peptides. An overview of the in vitro detected proteins is shown in Fig 2A.
In vivo proteomics of pneumococci recovered from the CSF revealed
ComDE and AliB expression during infection
One of the major challenges of host-pathogen interaction experiments is the elucidation of
basic adaptation and regulation mechanisms of the infiltrating pathogen and its primary host.
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A large fraction of molecules that mediate host-pathogen interactions are proteins and can
therefore be quantified by modern proteomics tools such as gel-free MS. In order to reduce
systems complexity for proteomic screens, in vitro assays have been used to mimic the natural
milieu of human pathogens. However, it is obvious that in vitro assays can only partially cap-
ture the complex interactions in murine animal experiments or human sample specimen.
Thus, more efforts should be invested to develop novel and sophisticated in vivo proteomics
approaches. Here, we addressed these problems by combining a dual filter extraction step,
high sensitive MS, and spectra-to-spectra database searches to identify for the first time S.
pneumoniae D39-specific proteins during bacterial meningitis in the presence of a highly com-
plex mouse protein background (Fig 1). We therefore restricted our analysis solely to S. pneu-
moniae D39 derived tandem-MS spectra and created a specific library with the SpectraST
search tool. This spectra-to-spectra analysis increased significantly the reliability of our identi-
fications compared to classical in silico-based searches, because interfering mouse peptides/
spectra were no longer misleadingly assigned as bacterial peptides.
However, due to the low number of isolated bacteria in our approach–approximately
200,000 recovered bacteria–and the presence of mouse proteins within the samples, the MS
data could only be used for identifications and present/absent predictions but not for further
dynamic quantification as, e.g., accomplished by the MS1 based “area under the curve” (AUC)
method. Despite these limitations we have identified more than 685 proteins in the control
representing proteins from pneumococci grown in vitro and digested on the filter and 249
Fig 1. Workflow applied for the identification of pneumococcal-specific proteins from mouse CSF isolates. In a first step, S. pneumoniae D39 specific tandem-MS
spectra from different conditions were measured and stored in a database (spectral library; SpectraST). Subsequently, proteins from S. pneumoniae in vivo experiments
were measured after dual filter extraction and digestion steps and compared and aligned to spectra deposited in the database. A subset of proteins exclusively identified in
vivo in the CSF was further considered for phenotypical characterization and for demonstrating its impact on pneumococcal meningitis.
https://doi.org/10.1371/journal.ppat.1007987.g001
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from the in vivo CSF samples using the SpectraST search tool (Fig 2A and 2B). Most of the
proteins were detected in both sample sets, and these proteins reflect as expected the most
abundant proteins of pneumococci, such as ribosomal proteins, proteins involved in DNA rep-
lication, peptidoglycan synthesis-related proteins, proteins of amino acid pathways or belong-
ing to the incomplete TCA cycle. However, some of the identified proteins were exclusively
Fig 2. Identification of ComDE and AliB in S. pneumoniae D39 from in vitro culture or in vivo infection samples. (A) Voronoi Treemaps of predicted and
detected pneumococcal proteins. S. pneumoniae D39 was cultured under various in vitro conditions, and a map of in vitro identified proteins was generated (left
panel). Pneumococcal proteins identified in control reactions with a trypsin-digestion of pneumococci on a filter (middle panel). These pneumococci represent
bacteria from a culture that was also used to infect mice. Proteins identified in pneumococci recovered from the CSF of mice (n = 5 samples each of 4 mice),
enriched by sequential centrifugation on a filter, and digested by trypsin (right panel). Gray spheroids represent annotated protein entries from the SEED with
light gray not identified in sample and dark gray never identified. Orange spheroids represent identified proteins by MS. (B) Identified proteins are depicted in
enlarged regions of Voronoi treemaps. ComD, ComE (upper left), and AliB (lower left) were not identified in S. pneumoniae D39 from in vitro culture samples,
while all three proteins were identified in samples from in vivo infection (upper and lower right).
https://doi.org/10.1371/journal.ppat.1007987.g002
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detected in the in vivo CSF samples from murine infections (Fig 2B). These proteins were
therefore of particular interest because they mirror the immediate response of S. pneumoniae
to the extrinsic host milieu. One of the identified proteins was part of the two-component sig-
nal transduction system ComDE, a key player in the competence but also virulence of S. pneu-
moniae. Another protein, referred to as AliB, is a component of an Ami-AliA/AliB permease
complex and has also been detected in the murine CSF samples but not on the filter control of
the inoculum (Fig 2). This protein is part of the ATP-binding cassette transporter and involved
in the uptake of small peptides [30]. All proteomics data can be accessed via the PeptideAtlas
(http://www.peptideatlas.org/).
Role of AliB and ComDE in pneumococcal meningitis
To decipher the functional role of AliB and ComDE in pneumococcal meningitis, we infected
mice intracisternally with 105 cfu of S. pneumoniae D39 or its isogenic ComDE-deficient,
AliB-deficient- or AliB-ComDE-double-deficient mutants (S1 Fig). D39 injection caused a sig-
nificant elevation of CSF leukocyte (WBC) counts (22,454 ± 6,356 cells/μl) compared to our
PBS (phosphate-buffered saline) control (294 ± 188 cells/μl) at 18 h post-injection, indicating
pneumococcal meningitis (Fig 3A). Mice infected with ComDE-deficient, AliB-deficient- or
AliB-ComDE-double-deficient mutants showed significant decreases in CSF pleocytosis
(Fig 3A).
We obtained divergent results for CSF concentrations of IL-1β and CXCL2. These cyto-
kines are implicated in leukocyte recruitment to the CSF during experimental pneumococcal
meningitis [9, 31]. Mice infected with mutant strains had lower CSF CXCL2 concentrations
than those infected with the wild-type D39 strain, albeit only the difference between mice
infected with the double-deficient mutant and the wild-type strain reached statistical signifi-
cance. Contrarily, CSF IL-1β concentrations were quite similar in all mice, irrespective of
whether mice were infected with the wild-type D39 or its isogenic mutants (Fig 3B and 3C).
The less pronounced CSF pleocytosis in mice infected with the mutants could also be due
to lower growth rates in the brain and the blood. This might be caused by a decrease in
Fig 3. Lack of ComDE and/or AliB results in an attenuated inflammatory response to pneumococcal infection of the CSF. Pneumococcal meningitis was induced by
intracisternal injection of wild type S. pneumoniae D39 (n = 13) or its isogenic ComDE-deficient, AliB-deficient- or AliB-ComDE-double-deficient mutants (each mutant
n = 8). Eighteen hours later, CSF white blood cell (WBC) counts (A), IL-1β (B), and CXCL2 (C) levels were determined. (A) Mice infected with the single or double
mutants showed significant decreases in CSF pleocytosis, as compared to D39 infected mice. (B) CSF IL-1β concentrations were quite similar in all mice, irrespective of
whether mice were infected with D39 or its isogenic mutants. (C) Conversely, mice infected with mutant strains had lower CSF CXCL2 concentrations than those infected
with D39, albeit only the difference between mice infected with the double-deficient mutant and the wild-type strain reached statistical significance. In negative controls
(mice injected i.c. with PBS instead of S. pneumoniae; n = 8), CSF leukocyte counts were 284 ± 188 cells/μl, whereas IL-1β and CXCL2 levels were below the detection
limit. Data are given as means ± SD. � P< 0.05, compared to mice infected with the D39 strain, using One-Way ANOVA and Tukey post-hoc test.
https://doi.org/10.1371/journal.ppat.1007987.g003
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bacterial fitness under these specific conditions. However, we found similar amounts of pneu-
mococci in brains of all infected mice, irrespective of whether they received a mutant or the
wild-type strain (Fig 4A). This is in accordance with our findings that the growth rates of
pneumococcal wild-type and mutants in chemically-defined medium (CDM) and CSF were
similar (S2 Fig). Strikingly, intracisternal inoculation of the mutants D39ΔaliB or D39ΔaliBΔ-
comDE was accompanied by significantly lower bacterial concentrations in the blood as com-
pared to bacterial titers found for the wild-type D39 and mutant D39ΔcomDE (Fig 4B).
We further measured physiological parameters like body temperature and body weight as
well as spontaneous motor activity to assess murine fitness post infection. In addition, we clini-
cally evaluated mice using an established scoring system. A clinical score of 0 indicates an
Fig 4. Loss of function of ComDE and/or AliB is protective in murine pneumococcal meningitis. Pneumococcal
meningitis was induced by intracisternal injection of wild type S. pneumoniae D39 or its isogenic ComDE-deficient,
AliB-deficient- or AliB-ComDE-double-deficient mutants. Eighteen hours later, the bacterial titres in the brain (A)
and blood (B), the clinical status (C), and the number of cerebral haemorrhages (D) were evaluated. (A) The bacterial
outgrowth within the CNS was comparable in all mice, irrespective of whether mice were infected with the wild-type
D39 or its isogenic mutants, (B) whereas mice infected with AliB mutants had significantly lower bacterial
concentrations in the blood. (C) Mice infected with ComDE-deficient, AliB-deficient- or AliB-ComDE-double-
deficient mutants showed reduced illness (indicated by lower clinical score values), as compared to D39 –injected
mice. (D) The ameliorated clinical course seems to be due to less pronounced brain pathology, as indicated by lower
numbers of cerebral haemorrhages in mice infected with the mutant strains. Negative controls (mice injected i.c. with
PBS instead of S. pneumoniae; n = 8) exhibited a clinical score of 0. Moreover, bacterial culturing and brain
examination for the presence of haemorrhages revealed negative results. Data are given as means ± SD. � P< 0.05,
compared to mice infected with the D39 strain, using One-Way ANOVA and Tukey post-hoc test.
https://doi.org/10.1371/journal.ppat.1007987.g004
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uninfected and healthy mouse, and a score of 12 is attributed to terminally ill mice. Our intra-
cisternal infection of mice with wild-type pneumococci led to a significant reduction in motor
activity (4.5 ± 4.1 fields/min), body temperature (36.8 ± 0.4˚C), and body weight (−11.3 ±
2.0%), which was paralleled by an increased clinical score (5.6 ± 1.1), as compared to unin-
fected control mice (40.0 ± 13.4 fields/min, 37.7 ± 0.3˚C, + 1.6 ± 2.6%, and 0.0 ± 0.0, respec-
tively). Mice infected with the mutant strains showed significantly higher motor activities (S3
Fig) and body temperatures as well as lower clinical score values compared to D39-infected
mice (Fig 4C), and thus less clinical impairment. Loss of body weight was significantly less pro-
nounced in mice inoculated with the double-deficient mutant than in those that had received
wild-type pneumococci (S3 Fig).
Clinical impairment is—at least partly–the result of meningitis-related pathologic changes
of the brain. Cortical haemorrhages are among the main pathologic findings in experimental
murine pneumococcal meningitis [32]. The number of (visible) hemorrhagic spots was signifi-
cantly lower in mice infected with the respective mutant strains than in mice infected with
wild-type pneumococci (Fig 4D).
Phenotypic characterization of AliB and ComDE deficient pneumococci
The attenuation of mutants deficient in AliB or ComDE in the experimental meningitis model
could be associated with dramatic phenotypic changes, lower resistance against oxidative
stress, or alteration in key virulence factor expression. Because growth rates in CDM or CSF
were similar, we further compared the growth of wild-type and isogenic mutants under
different stress conditions. We determined survival rates of mutants deficient for AliB,
ComDE or both, AliB and ComDE, in the presence of various concentrations of the oxidizing
agents hydrogen peroxide (H2O2) or the superoxide generating paraquat (methyl viologen;
[(C6H7N)2]Cl2). Our comparative analysis revealed similar survival rates for all mutants and
the wild-type D39 suggesting that free reactive oxygen species during meningitis did not
impair bacterial outgrowth in CSF (Fig 5A). In addition, we analysed the relative amount of
capsular polysaccharide (CPS) by flow cytometry and the production of pneumolysin by
immunoblot analysis and a haemolysis assay. The results demonstrated similar amounts of
CPS and pneumolysin for the mutants and wild-type D39 (Fig 5B–5E). Thus, pneumococcal
fitness and key virulence determinants were unaffected under the selected in vitro conditions.
In vitro proteome analysis of pneumococci lacking functional AliB or
ComDE
In vitro comparisons between the AliB-deficient or ComDE-deficient and isogenic wild-type
pneumococcal strains were performed in the two phases of early (OD600 0.12 to 0.15) and
mid-exponential growth (OD600 0.45 to 0.5) in a chemically-defined medium [33] resembling
the nutrients available in CSF. Proteins displaying a combination of a p-value less than 0.05
and a fold change of at least 1.5 or with status present/absent (on/off) were considered as sig-
nificantly regulated. Taking all the data together, a total of 1150 proteins were identified,
which is roughly 70% of the theoretical proteome. Only a very small proportion of these pro-
teins displayed significantly different levels between the different mutants and the wild-type in
the different growth phases. The abundance of 24 and 11 proteins differed between ComDE-
deficient pneumococci and the wild-type in early and mid-exponential phase, respectively (Fig
6A, S1 Table and S5 Table). When comparing AliB-deficient pneumococci with the wild-type,
33 proteins differed in abundance during early exponential growth and 50 proteins during
mid-exponential growth phase (S1 Table). In general, all bacterial samples showed high levels
of AliA, which is the substrate-binding protein of the oligopeptide ABC transporter (Fig 6A).
In vivo proteomics of pneumococci explores essential factors during meningitis
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Beside other proteins, the Ami oligopeptide ABC transporter consisting of AmiA, AmiC
AmiD, AmiE, and AmiF showed significant lower abundances in the ComDE-deficient pneu-
mococci during early exponential growth compared to the wild-type. These proteins represent
the substrate-binding protein, ATP-binding proteins and permeases encoded in a single
operon (spd_1666, spd_1667-1668-1669-1670) [30, 34].
Proteins that increased in abundance included, for example, PyrF, PyrE, PyrDb, PyrB, and
PyrR of the pyrimidine metabolism pathway (Spd_0608-0609-0852-1131-1133-1134) and the
response regulator RR4 (Spd_1908 or PnpR). The increased abundance of the Pyr-proteins
was not detected anymore during mid-exponential growth. AmiA, AmiC, AmiD, AmiE, and
AmiF were still detected at slightly decreased levels during mid-exponential growth phase in
ComDE-deficient pneumococci when compared to the wild-type (S1 Table). AmiF is included
in the list of proteins with decreased abundance during mid-exponential phase despite their
fold change is only −1.498, which did not pass the cut-off. Nevertheless, with this very small
difference to the cut-off value of −1.5 also AmiF can be regarded as decreased. In contrast,
AmiA seems to be switched off.
Interestingly, the oligopeptide ABC transporter proteins AmiE, AmiD, AmiC as well as
AmiA but not AliA displayed decreased abundances in AliB-deficient pneumococci when
compared to the wild-type during early exponential and mid-exponential growth (Fig 6B).
Similar to the comDE mutant, the abundance of AmiA and AmiF was only significantly
affected during early exponential phase in the AliB-deficient strain, but did not pass the fold
change cut-off in mid-exponential phase (fold change switched off and fold change −1.27).
Relatively high increases in protein abundance (fold change 24.6 to 107.5 or switched on)
were observed in AliB-deficient pneumococci for the ABC transporter permease (Spd_1607),
ABC transporter ATP-binding protein (Spd_1608), ABC transporter substrate-binding pro-
tein (Spd_1609), and a hypothetical protein (Spd_1610) during early exponential as well as
mid-exponential phase (S1 Table). The proteins Spd_1606–1610 are all encoded in the operon
804 (Fig 6) [35]. The MgtC/SapB family protein (Spd_1606) was not detected with our
approach.
Discussion
Pneumococci conquer various human host compartments and dissemination as well as sur-
vival requires the pathogen´s adaptation to the specific pathophysiological conditions of their
environment [15]. Critical factors for pneumococcal fitness are the availability of nutrients
such as carbon sources, amino acids, or metal ions [33]. In addition, pneumococci have also
evolved strategies to escape the immune defence system of the host. This is undoubtedly as
important as physiological fitness, because pneumococci are, depending on the stage of coloni-
zation or invasive infection, exposed to various factors of the immune system. Hence, it is
Fig 5. Stress resistance and virulence factor expression of ComDE and AliB-deficient pneumococci. (A) Stress resistance and
robustness of pneumococci deficient in AliB, ComDE, or AliB and ComDE against hydrogen peroxide (H2O2) and superoxide producing
compound paraquat. (B) and (C) Determination of the relative amount of pneumococcal capsular polysaccharide (CPS) on the surface of
D39 and its isogenic S. pneumoniaeΔcomDE-, ΔaliB- and ΔcomDEΔaliB-mutants using a flow cytometry approach. An anti-serotype 2
specific antiserum and a goat anti-rabbit IgG coupled Alexa-Fluor-488 were used to detect the CPS. A similar increase of fluorescence
intensity (FL-1-H) measured for the wild-type D39 and its isogenic mutants indicated similar amounts of CPS on the surface of all tested
pneumococci. Shown are flow cytometry histograms of representative experiments in (B) and in (C) the results of three independent
experiments (n = 3). (D) The relative amount of the pneumococcal toxin pneumolysin was investigated by immunoblot analysis using a
specific mouse anti-pneumolysin or PsaA (loading control) antiserum and secondary anti-mouse IgG conjugated IRDye 800CW for Ply
detection and a secondary anti-mouse IgG coupled with IRDye 680RD for PsaA detection. (E) The haemolytic activity of pneumolysin in
wild-type D39 and its isogenic mutants was compared by applying a haemolysis assay. Pneumococci were cultured in THY to OD600 of 0.8
or to OD600 of 1.2, and the supernatants were incubated for 30 min with red blood cells. The haemolytic activity is indicated lysis of the red
blood cells while a red blood cell pellet was formed in absence of haemolytic activity.
https://doi.org/10.1371/journal.ppat.1007987.g005
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essential that the repertoire of fitness and virulence factors expressed by pneumococci is
adapted to the environmental cues of the host compartment. Only a tightly regulated adapta-
tion process enables a highly efficient consumption of available nutrients, which is accompa-
nied by de novo synthesis of e.g., amino acids. Furthermore, alterations of the repertoire of
virulence factors provoke modulation of the host response and prevent killing by host immune
factors [36].
In this proteome-based study we have recovered pneumococci from the CSF of mice and
identified pneumococcal proteins that are abundant or upregulated during experimental
pneumococcal meningitis. The CSF is a water-like, crystal clear fluid with very few cells (below
5 cells/μL), a low protein content (approximately 0.2% of blood total protein) as well as a lower
pH, lower glucose and cholesterol concentrations, but higher chloride concentrations, as com-
pared to the blood [37–39]. Following pneumococcal infection, substantial numbers of blood-
borne leukocytes are recruited into the CSF. The CSF protein concentration increases and the
protein and ion composition changes dramatically, both mainly due to the breakdown of the
blood-CSF barrier. In addition, glucose levels can go down as low as zero [40, 41]. The dynam-
ics and complexity of these CSF alterations can hardly be mimicked under in vitro conditions,
Fig 6. Comparison of proteins with differential abundance between S. pneumoniaeΔcomDE or ΔaliB strains and the wild-type (wt) strain using a Venn diagram.
(A) Comparison of proteins with differential abundance between ΔcomDE or ΔaliB strains and the wild-type (wt) strain in early exponential (early exp.) and mid-
exponential (mid-exp.) growth phase using a Venn diagram. (B) The schematic models show interesting proteins involved in the infection process. The intensities of the
proteins were calculated from the mass spectrometry data as area under the curve (AUC). A low concentration of the protein in the sample is shown as green and a high
concentration as red. Significantly regulated proteins compared to the wild-type are marked with � or #.
https://doi.org/10.1371/journal.ppat.1007987.g006
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underlining the need of in vivo investigations. We hypothesized that the global proteome anal-
ysis of pneumococci isolated from the CSF will identify proteinaceous factors involved in the
pathophysiology of meningitis and that the results will support the understanding of molecular
mechanisms of this life-threatening disease. With our experimental setup the pneumococcal
oligopeptide transporter AliB and the two-component regulatory system ComDE were exclu-
sively detected in the in vivo CSF compartment. However, this does not exclude that these pro-
teins may not be produced under different in vivo conditions. The contribution of AliB and
ComDE to pneumococcal colonization, but not invasive disease, has been demonstrated ear-
lier [42, 43]. However, their role in pneumococcal meningitis had not been studied so far.
Thus, we explored the influence of the oligopeptide transporter AliB and the two-component
regulatory system ComDE on pneumococcal meningitis. Our results clearly proved their criti-
cal role in the development of severe pneumococcal meningitis. The significant attenuation of
pneumococcal mutants in the experimental meningitis model did not rely on growth defects
or diminished expression of crucial virulence factors such as the capsule or cytotoxin pneumo-
lysin. Because of its important role in pneumococcal meningitis [9, 44], a reduction in pneu-
molysin production would have been an explanation for the significantly reduced clinical
scores and cortical haemorrhages in the presence of similar cerebellar bacterial titres. In addi-
tion, the robustness of pneumococci lacking AliB or ComDE expression against oxidative
stress was not affected, suggesting that the induced reactive oxygen species during meningitis
are not the limiting factors. Strikingly, the comDE-mutant showed similar CFU in the blood
compared to the wild-type, whereas the aliB-mutant had significantly lower blood titres, point-
ing to the inability of the aliB-mutant to transmigrate form the CSF into the blood in our
model. Interestingly, non-encapsulated pneumococcal strains produce AliB-like proteins,
named AliC and AliD. These strains are associated with colonization and non-invasive dis-
eases including non-bacteremic pneumonia [45, 46]. Consistent with these findings mutants
with loss of function of AliC or AliD did not cause pneumococcal meningitis [47].
A substantial limitation of in vivo transcriptomics and our in vivo proteomics approach was
the low number of pneumococci recovered from the distinct in vivo host compartments.
Other in vivo proteomics studies faced identical problems, when investigating pneumococcal
proteins in the presence of host proteins, and identified therefore a very small number of bac-
terial proteins. The authors clarified that in vivo proteome studies of pathogenic pneumococci
will only be feasible with new and specialized techniques [48]. In a former study, when analys-
ing the proteome of Staphylococcus aureus, we had the same experience [25]. In this study we
therefore developed a new filter enrichment and spectral library evaluation strategy to cope
with the small amounts of bacteria. With this method, we were able to extract a maximum of
50,000 bacteria from the CSF of a single mouse. Because this is still a relatively low number of
bacteria, we have tried to increase the amount of infected CSF to be filtered. However, this
ended up with an excess of host proteins, which were increasingly identified in MS.
In spite of the presence of eukaryotic proteins and low numbers of bacterial proteins, the
dual filter extraction step and the generation of a highly specific pneumococcal SpectraST
library enabled us to identify 249 proteins even in the presence of a large excess of host pro-
teins under in vivo conditions. To put this in relation, in a similar approach 578 proteins were
identified from Staphylococcus aureus recovered from the upper respiratory tract of intrana-
sally infected mice [25]. However, while we have identified in total only 685 pneumococcal
proteins by on-filter digestion from in vitro experiments, Michalik et al. identified in total
1,719 proteins over all samples after sorting of 5 x 106 S. aureus cells by on-filter digestion.
These differences are probably due to the higher number of recovered bacteria, a higher
robustness of S. aureus compared to the autolytic pneumococcus and a higher efficiency of the
tryptic digest with S. aureus.
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A prerequisite for our robust in vivo proteomics approach was the generation of a Spec-
traST library, which contains high number and high quality tandem-MS reference spectra for
the organisms of interest. Our comprehensive pneumococcal SpectraST library contained
49,083 tandem-MS spectra reflecting 1,165 protein identifications. Similar to our study a S.
aureus SpectraST library from a comprehensive set of peptide data was used for the identifica-
tion of S. aureus proteins [49]. Those SpectraST libraries and the appropriate PeptideAtlas
entries are valuable proteome repositories facilitating in mixed host-pathogen samples or in
contaminated samples targeted proteome analysis and if possible, proteome quantification
[25, 49].
We were intrigued to identify AliB and ComDE as upregulated bacterial factors when
pneumococci disseminate in the CSF. Several studies have already addressed pneumococcal
adaptation and its in vivo host-compartment specific gene expression by examination of the
transcription pattern. In addition to genome-wide in vivo transcriptomic analyses other
sophisticated molecular techniques have been employed to identify key pneumococcal players
under in vivo conditions. One of these studies identified upregulated genes in the nasophar-
ynx, lungs or blood such as e.g., aliA, comB and other competence genes [24]. This study fur-
ther showed that immunization with AliA protects against pneumococcal infections. A follow-
up microarray analysis identified genes differentially expressed in the nasopharynx and blood
such as the genes encoding the superoxide dismutase, the serine protease PrtA, proteins part
of transport systems as well as ComE [22]. Using an experimental rabbit meningitis model and
the microarray-based GAF (genomic array footprinting) technology genes were identified that
were attenuated during meningitis. Strikingly, this approach did not identify competence
genes or genes encoding proteins of the Ami system including AliA and AliB [23]. More
recently, the transcriptome of S. pneumoniae D39 has been analysed under 22 different infec-
tion-relevant, but not in vivo conditions including growth in CSF-mimicking conditions.
Intriguingly, comDE is significantly upregulated in CSF mimicking conditions and cell culture
infection experiments with A549 cells (https://veeninglab.com/pneumoexpress-app/index.
php). In contrast genes of the Ami-AliA-AliB system have not been identified to be upregu-
lated in CSF-mimicking conditions, suggesting that the in vivo host environment plays a fun-
damental role in modulating gene expression [50].
ComDE is one of the 13 two-component regulatory systems (TCS) of pneumococci
(TCS12) and is a master regulator of competence. However, ComDE is further involved in
antibiotic resistance and regulation of virulence factors[51–54]. Competence is auto-con-
trolled via the comCDE operon, where comC encodes the proactivator that is exported by the
ComAB machinery [55]. The mature form of ComC, known as competence stimulating pep-
tide, activates the histidine kinase ComD, which subsequently leads to activation of the
response regulator ComE [52]. Importantly, ComE regulates early competence genes like
comX and comW, which in turn activate the expression of late competence genes including
those encoding the peptidoglycan hydrolases CbpD and LytA. To avoid committing suicide,
competent pneumococci protect themselves against CbpD by expressing the immunity protein
ComM, which is encoded by an early competence gene [56]. The link between competence
and virulence has been indicated by the impairment of pneumococci deficient in ComD or
ComX to cause pneumonia and bacteraemia in mice [18, 54, 57]. Here, we show in addition
that regulation of competence genes is also crucial for pneumococcal meningitis, probably by
the mode of action of the alternative sigma factor ComX, which regulates genes associated
with cell wall turnover and virulence [54, 58].
Induction of the competent state in S. pneumoniae leads to the expression of several pro-
teins that alleviate stress, e.g. the heat shock proteins ClpL, GrpE, DnaK, DnaJ, and HtrA that
function to disaggregate, refold, and/or degrade misfolded proteins [59, 60]. Interestingly, the
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CiaR and LiaR regulons, which are activated in response to cell envelope stress, are both upre-
gulated in competent pneumococci. Presumably, stress proteins are expressed to alleviate the
temporary stress imposed during the competent state. However, since some types of external
stress can induce competence, it is also possible to regard competence as a stress response
mechanism itself [59, 61–64]. Hence, the upregulation of ComDE and competence observed
in pneumococci during meningitis might be a stress response mounted by the bacteria to
defend themselves against attacks from the host immune system.
AliB is a lipoprotein and substrate-binding protein (SBP) of the Ami system, the only oligo-
peptide ABC transporter system identified in pneumococci. Other oligopeptide-SBPs of the
Ami system are the lipoproteins AmiA and AliA, sharing approximately 60% identity to AliB
[30]. A triple mutant devoid of all three oligopeptide-SBPs is impaired in oligopeptide uptake
and interestingly, the lack of AliB reduced competence [30, 34]. However, it is important to
mention here that the Ami system is not directly involved in the response to the competence
stimulating peptide CSP encoded by ComC [65]. The Ami system further consists of the ATP-
binding proteins AmiE and AmiF and the permeases AmiC and AmiD and loss of function in
AmiDEF inhibited uptake of all tested oligopeptides [30]. Other studies identified an aliB-like
ORF in the capsule region of non-encapsulated pneumococci [66], which may compensate the
deficiency in the three SBPs of the Ami system. While amiABCDEF are part of a polycistronic
operon, AliA and AliB are located in other genomic regions and are independently regulated
from each other and AmiA.
Growth studies and in vivo infections indicated that loss of function of AmiA and AliA can
be compensated in vitro and in vivo by AliB. Despite that all three oligopeptide-SBPs are
required for successful colonization of the nasopharynx, the deficiency in AliB had the slightest
impact on colonization, while AliA or AmiA affected colonization dramatically [30, 42]. This
suggested differences in their substrate specificity. Indeed, the aliB-mutant was unable to grow
on Arg-Pro-Pro and Arg-Pro-Pro-Gly-Phe as oligopeptides, while pneumococci lacking AliA
and AliB could use only Leu-Leu-Leu oligopeptides. A substrate-specificity for AliB has been
suggested for peptides Arg-Pro-Pro and Leu-Arg-Arg-Ala-Ser-Leu-Gly, respectively [30]. In a
recent study Ami-AliA/AliB ligands have been identified. AmiA binds peptide AKTIKITQTR,
AliA peptide FNEMQPIVDRQ and AliB peptide AIQSEKARKHN. Interestingly these pep-
tides are part of 50S or 30S ribosomal proteins found in species of γ-proteobacteria, which are
commensals of the upper respiratory tract [47].
Despite the functional redundancy between AmiA, AliA, and AliB, we could not observe a
compensation of loss of function of AliB in our experimental meningitis infection model. The
aliB-mutant is attenuated as indicated by significantly decreased bacterial titres in the blood,
lower clinical score values, and less pronounced brain pathology. This suggests that under the
given conditions in the meningitis model, AmiA and AliA cannot fully compensate for the loss
of AliB. The absence of AliB leads to uptake of a reduced spectrum of oligopeptides, which pre-
sumably results in the deficiency of essential amino acids. This in turn leads to lower fitness
and lower virulence during infection of the subarachnoid space. This is in contrast to a coloni-
zation model, in which AliB had only a minor effect, while the impact was more pronounced
for AmiA and AliA [42]. However, we are not aware of any study that has assessed the individ-
ual impact of AmiA or AliA on pneumococcal meningitis. Importantly, our in vitro proteome
analysis of the mutant deficient in AliB revealed that the amount of AliA is high in the wild-
type and the aliB- or comDE-mutant as well. In contrast, the protein amount of AmiA is signif-
icantly decreased in the early and mid-exponential growth phase of aliB-mutants. Surprisingly,
AmiA and its cognate permease as well as ATPase are also significantly reduced in the comDE-
mutant of D39. The reason for this coincidence is not clear, but may contribute to the attenua-
tion of our mutants.
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AmiA is also affected by loss of function of AliB. This probably further reduces the spectrum
of oligopeptides that can be taken up by pneumococci as has been shown earlier [30]. Because
pneumococci are auxotrophic for several amino acids [33, 67] this has consequences for nutri-
tion and protein synthesis. Under conditions where the amino acid pool is unbalanced mis-
charging of tRNAs takes place [68] and premature termination of protein synthesis will happen.
Hence, in an aliB-mutant, where the expression of AmiA is strongly reduced as well, mischarg-
ing of tRNAs and premature termination will lead to the production of truncated and misfolded
proteins due to declined uptake of amino acid [30]. This situation is most likely stressful for
pneumococci as indicated by an upregulation of ClpL (ATP-dependent Clp protease; Spd_0308)
in the aliB- and comDE-mutant as well. In contrast, another protease, the extracytoplasmic pro-
tease HtrA, which represses competence by digestion of CSP, was not significantly altered.
While the Ami system is important for uptake of peptides, other ABC transporters, as for
instance iron transporters, are crucial for ion homeostasis like iron transporters. Pneumococci
acquire iron via PiaABC and PiuABC, however, the proteome analysis indicated no changes in
abundance in mutants deficient in AliB or ComDE. Similar, other transporters were not
affected with the exception of the PTS system transporter protein SPD_0661 (2-fold) and a
potential ABC iron-transporter system encoded by the operon 804. This operon encodes the
proteins SPD_1606 to SPD_1610 with the lipoprotein SPD_1609 as SBP of the system [35].
Proteins encoded by this gene cluster were more than 20-fold upregulated in the aliB- but not
comDE-mutant, suggesting a compensatory effect.
Material and methods
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals (National Research Council, USA) and with the German
Animal Protection Act. The study protocol was approved by the Committee on the Ethics of Ani-
mal Experiments of the Government of Upper Bavaria (Permit Numbers: 55.2-1-54-2531-31-09
and 55.2-1-54-2531-143-12). All efforts were made to minimize suffering, ensure the highest ethi-
cal standards, and to adhere to the 3R principle (reduction, refinement and replacement).
Bacterial strains and growth conditions
Bacterial strains and recombinant plasmids used in this study are listed in S2 Table. Streptococ-
cus pneumoniae was cultivated in Todd-Hewitt broth (Roth) supplemented with 0.5% yeast
extract (THY) or in chemically-defined medium (RPMImodi = CDM) [33] without agitation at
37˚C. Serotype 2 strain D39 was chosen for the in vivo study because the disease course and
pathology associated with this serotype has been extensively studied in rodent models (in
which the bacteria are directly injected into the cerebrospinal fluid or the brain), thus allowing
broad comparison of results [69]. Genetically modified pneumococci were selected on Colum-
bia blood agar plates (Oxoid) supplemented with 5% defibrinated sheep blood, and antibiotics
were added as appropriate including kanamycin (Km 300 μg/ml) and chloramphenicol (Cm
2 μg/ml). Recombinant E. coli were grown in Luria–Bertani (LB) medium at 30˚C under agita-
tion (110 rpm) or on LB agar plates. The following antibiotics were added for different recom-
binant E. coli: Km 50 μg/ml, Cm 20 μg/ml).
Growth and survival of S. pneumoniae under oxidative conditions
Pneumococcal wild-type D39 and isogenic mutants D39ΔaliB, D39ΔcomDE or D39ΔaliBΔ-
comDE were cultured in complex THY medium at 37˚C up to mid-exponential growth phase
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(OD600nm 0.5–0.6). Bacterial cultures were then splitted and hydrogen peroxide (final concen-
tration 10 mM or 20 mM) or paraquat (final concentration 0.25 mM or 0.5 mM) was added,
and samples were incubated at 37˚C for 30 min [70]. Untreated pneumococcal cultures were
used as control. Serial dilutions were then plated on blood agar plates and incubated overnight
at 37˚C and 5% CO2. Survival rates of mutants were determined by counting the cfu and com-
paring them to the cfu of untreated bacteria.
Protein extraction and enzymatic digestion of samples from in vitro
experiments
To prepare a qualitative pneumococcal SpectraST library we cultured D39 and TIGR4 as well
as pneumococcal mutants (Δcps; Δrex) pneumococci under various conditions including
higher temperature (40˚C) and various stress conditions (hydrogen peroxide, sodium
hypochloride, and paraquat). Cell disruption of bacteria was performed using a bead mill, a
freezing and thawing procedure, or by direct tryptic digestion after transfer of the bacteria on
a filter membrane. For the first and second method we determined protein concentrations in
the resulting cell lysates and performed a tryptic digestion with 4 μg of protein per sample. The
filter membrane digestion was performed with a cell count of approximately 107 bacteria to
reach sufficient protein quantities. Afterwards, the crude peptide mix from all cell disruption
methods was purified and desalted with C18 ZipTip material (Merck Millipore, Merck KGaA,
Darmstadt, Germany).
In vivo infection of mice and bacterial isolation via dual filter extraction
We used a well-characterized mouse model of pneumococcal meningitis [31, 71]. Briefly,
8–12 weeks old male C57BL/6n mice were weighed and their body temperature was
recorded. Their spontaneous motor activity was determined using an open field test device.
Then, mice were clinically examined and scored. Clinical scoring comprised [i] a beam bal-
ancing test, [ii] a postural reflex test, [iii] the presence of piloerection, seizures or reduced
vigilance. In healthy animals, the score is 0 points; twelve points are attributed to terminally
ill animals that have to be euthanized and excluded from the experiment. After clinical
evaluation, all mice received analgesic therapy with buprenorphine. One hour later, we
induced meningitis by intracisternal injection of 10 μl of S. pneumoniae suspension contain-
ing 107 colony forming units (cfu) per ml under short term anaesthesia with isoflurane. Mice
were infected with the following pneumococcal strains: D39, D39ΔaliB, D39ΔcomDE, and
D39ΔaliBΔcomDE. For virulence experiments, mice were randomly allocated to the four dif-
ferent groups by drawing cards before infection. Animals were allowed to wake up, and food
and water were supplied ad libitum. At 18 hours after infection, mice were clinically exam-
ined and then anaesthetized with ketamine/xylazine. A catheter was placed into the cisterna
magna. CSF samples were withdrawn either to recover bacteria for proteomics analysis or to
determine CSF leukocyte counts as well as CSF IL-1β and CXCL2 concentrations for viru-
lence analyses of mutant strains. After intraperitoneal pentobarbital injection, chests were
opened, and blood samples were taken by transcardial puncture. Thereafter, mice were per-
fused with 15 ml ice-cold PBS containing 10 U/ml heparin. The brains were removed and
assessed for the presence of visible cortical haemorrhages. The cerebella were dissected and
homogenized in sterile saline. Blood samples and cerebellar homogenates were diluted seri-
ally in sterile saline, plated on blood agar plates, and cultured for 24 h at 37˚C with 5% CO2.
All mentioned outcome parameters were assessed by an investigator blinded to group
allocation.
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Measurement of CSF leukocyte counts, CSF IL-1β, and CXCL2
concentrations
Two μl of CSF were diluted with 18 μl Turk’s solution and used for leukocyte counting in a
Fuchs-Rosenthal chamber. The remaining CSF was diluted 1:20 in PBS. Fifty μl of each sample
were used to quantify IL-1β and CXCL2 concentrations by ELISA (R&D Systems, Wiesbaden-
Nordenstadt, Germany).
Bacterial sampling from infected mice
To isolate and enrich pneumococci from the CSF of infected mice, we developed a two-step
centrifugation procedure across a microfilter that allowed fast and reliable separation of bacte-
ria and host cells from CSF samples of mice subjected to bacterial meningitis. Bacterial inocu-
lum suspensions (used for the induction of meningitis) as well as CSF samples (mean volume
9.8 ± 3.9 μl) were diluted 1:40 in PBS containing 0.1% bovine serum albumin (BSA). The solu-
tions were passed through Whatman Puradisc syringe filters (pore size 1.6 μm; pre-coated
with BSA) in order to remove host cells. Ten μl of each filtrate were then used to enumerate
bacteria by plating and culturing. The remaining filtrates were centrifuged through filter units
with Durapore PVDF membranes (pore size 0.22 μm; pre-coated with BSA) in order to recover
the extracellular pathogens. The bacteria trapped by the 0.22 μm filters were immediately
stored at −80˚C until further processing. In pilot experiments, CSF either taken from single
mice or pooled from groups of 4 and 8 mice were subjected to bacterial counting and proteo-
mics analysis in order to identify the sample size that yielded the highest detection rate of bac-
terial proteins. The mean numbers of bacteria recovered from CSF samples taken from one, 4,
and 8 mice accounted to 49,100 ± 27,200 cfu, 317,600 ± 50,500 cfu, and 350,500 ± 78,500 cfu,
respectively. Subsequent proteome analyses revealed that the bacterial numbers obtained from
a single mouse were too low to allow protein detection, whereas the results were similar in
samples pooled from 4 or 8 mice with approximately 200 detectable proteins in each group.
In vitro growth of ΔcomDE and ΔaliB mutants and their corresponding
wild-type strain for harvest of samples intended for proteomics growth-
phase-specific strain comparisons
Pneumococci were cultivated sequentially on blood agar plates, first for 8 h and afterwards on
fresh plates for another 10 h. RPMI1640 medium was inoculated to an OD600nm of 0.06 using
bacterial material from the blood agar plates. Bacteria were grown at 37˚C without shaking.
Samples were harvested at early exponential growth phase (OD600 0.12 to 0.15) and at mid-
exponential growth phase (OD600 0.45 to 0.5) by centrifugation. Bacterial cells were washed
with PBS and stored at −80˚C. Bacterial cell disruption and preparation of protein extracts
were performed as described above for samples used for building the SpectraST library.
Protein extraction and enzymatic digest from dual filter extraction in vivo
experiments
Bacteria derived from CSF samples were submitted to a direct on-membrane digestion to
avoid any loss of material. Each filter (Ultrafree-MC, GV 0.22 μm, Merck Milipore, Germany)
was soaked in 60 μl 20 mM ammonium bicarbonate containing 13 ng trypsin and incubated
overnight at 37˚C. Resulting peptides were centrifuged through the filter for 5 min at 15,700 g
and the digestion reaction was stopped by adding trifluoroacetic acid to a final concentration
of 0.1%. Afterwards the peptide purification and desalting was achieved with C18 ZipTip
columns.
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Mass spectrometry analysis
Peptides were dried using a vacuum centrifuge concentrator and afterwards dissolved in LC
buffer A (2% acetonitrile, 0.1% acetic acid in HPLC-grade water) for the measurement.
LC-MS/MS analyses of pneumococcal samples from cultivation experiments were performed
by peptide separation on a Thermo Scientific Easy nLC II using a NS-MP-10 Biosphere C18
with 100 μm inner diameter and 20 mm length (Nano Separations, Netherlands) as pre-col-
umn and an Acclaim PepMap 100 with an inner diameter of 75 μm and a length of 15 cm
packed with C18 material (Thermo Scientific, USA) as analytical column. Separation of pep-
tides was achieved by a non-linear gradient starting at 2% LC buffer B (0.1% acetic acid in ace-
tonitrile) and 98% LC buffer A with an increasing LC buffer B proportion to 5% in the first
minute, to 25% until minute 60, to 40% until minute 70, and finally to 100% until minute 78.
Elution was performed at a flow rate of 0.3 μl/min, and following mass analysis was performed
with a LTQ Orbitrap Velos (Thermo Electron Corporation, Germany) equipped with a nano-
ESI source using a Picotip Emmitter (New Objective, USA). Ionization was set to positive
mode, a data-dependent acquisition Top 20 method was applied with full scans covering the
m/z range of 300–1,700 at a resolution of 30,000 with a target value of 1E6. Only charge states
+2 and +3 ions were subjected to fragmentation by CID with an isolation width of 2 Da and at
normalized collision energy of 35%. Targeted ions were afterwards excluded from fragmenta-
tion for 60 s using a dynamic exclusion list.
LC separation of bacterial samples from on-filter digestions was conducted with a nanoAcquity
UPLC (Waters Corporation, USA) using a 2G-V/M trap Symmetry C18 pre-column of 20 mm
length and 180 μm inner diameter (Waters Corporation, USA) and a nanoAcquity BEH130 C18
analytical column of 10 cm length and 100 μm inner diameter (Waters Corporation, USA). Pep-
tide separation was achieved by a non-linear gradient starting at 1% LC buffer B and 99% LC
buffer A with an increasing LC buffer B proportion to 5% until minute 2, to 25% until minute 65,
to 60% until minute 90, and finally to 100% until minute 91. Elution was performed at a flow rate
of 0.4 μl/min, and subsequent mass analysis was performed as described above.
All raw-files were submitted to a sequence database (NCBI 2014, 1914 proteins, 145357
peptides) search using the Sorcerer platform and trans-proteomic pipeline (TPP) [72]. No
static modifications were set, the peptide mass tolerance was set to ± 20 ppm, and a maximum
of two missed cleavages was allowed. For SpectraST library inclusion a minimum probability
of 0.95 was required.
Mass spectrometric analysis of in vitro cultivation samples of ΔcomDE and
ΔaliB mutants and their corresponding wild type strain
Samples of in vitro cultivated S. pneumoniae wild-type and ΔcomDE and ΔaliB mutants were
analysed using an LC-MS/MS system of an UltiMate 3000RSLC (Thermo-Fisher Scientific,
Idstein, Germany) and a Q Exactive Orbitrap-MS (Thermo-Fisher Scientific Inc.) in data-
dependent mode. Each sample consisted of 2 μg of purified tryptic peptides. Detailed settings
for LC-MS/MS are listed in S4 Table.
Identification of peptides via spectral library from in vivo experiments
To identify proteins in the CSF-derived bacterial samples we submitted the raw-files to a Spec-
traST search tool from the Trans-Proteomics Pipeline using the described library (http://tools.
proteomecenter.org/wiki/index.php?title=Software:TPP). For the selection of high quality
spectra matches the result files were filtered by dot score (� 0.6 required) and m/z difference
of ± 0.01 Da at maximum.
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Analysis of MS data from samples of ΔcomDE and ΔaliB mutants and their
corresponding wild type strain in different growth phases
A set of 24 MS raw data files (3 strains, 2 growth phases, 4 biological replicates per condition)
was analysed using MaxQuant software package [73] with parameter settings for label-free
quantitation. Trypsin/P (specific, i.e. full-tryptic) and up to 1 missed cleavage were set for
digestion. Oxidation of methionine was allowed as variable modification. MS data were
searched using a database of 1986 pneumococcal protein sequences (NCBI, D39, NCTC 7466),
to which reversed entries and contaminant sequences were added by the MaxQuant software
during analysis. Protein LFQ intensities were built and exported to Excel. After removal of
contaminant, reversed, and protein group identifications, the remaining data were imported
to the GeneData Analyst (GeneData AG, Basel, Switzerland) software package where log10-
transformation and a further median normalization were conducted. Non-logarithmized val-
ues were subjected to growth phase-specific, group-wise statistical comparison between the
strains using 2-group t-test under the restriction of at least 75% valid values per group (i.e. 3 of
4 replicates must have given a quantitative value). Finally, p-values and normalized intensities
were exported back to Excel for calculation of mean intensity values from all 4 replicates per
condition and for fold change calculation from these mean values. Proteins with p-values of
0.05 or less and absolute fold change values of at least 1.5 were regarded as regulated.
Visualization of detected proteins by Voroni Treemap
According to their function, SEED [74] S. pneumoniae D39 gene ontology classifies genes/pro-
teins in an acyclic multi-hierarchical tree-graph. Voronoi Treemaps [75] were used for a
graphical planar representation of this tree-like structure. Our Voronoi treemap-based layout
of SEED ontology intuitively visualizes the proteome coverage of general cell functions by our
in vitro and in vivo proteomics based approaches.
Molecular biology techniques
Isolation of plasmid DNA was performed as recommended by the supplier of the DNA isola-
tion kit (Promega). PCR reactions were carried out with Taq polymerase or Pfu polymerase
(New England Biolabs, Germany). Genomic DNA isolation from pneumococci was performed
by a fast preparation method. Briefly, pneumococci were cultivated in THY medium to
OD600nm of 0.3 to 0.4. Samples of 200 μl were centrifuged at 10,000 g for 2 min. The bacterial
sediment was resuspended in 100 μl PBS and centrifuged at 10,000 g for 4 min. Supernatants
were carefully removed, and pneumococci were resuspended in 50 μl sterile water and incu-
bated for 8 min at 96˚C. After cooling at room temperature another centrifugation at 10000 g
for 2 min was performed. Samples were then frozen at −20˚C for 30 min. Two μl were used as
DNA template for a PCR. Primers used in these studies were synthesized by Eurofins MWG
Operon and are listed in S3 Table. Recombinant plasmids were transformed into competent E.
coli DH5α treated with CaCl2.
Generation of aliB- and comDE-mutants
The deletion insertion mutagenesis of aliB has been described previously [30]. A D39 strain
harbouring the aliB mutation by insertion of a chloramphenicol cassette in the 5’-region of
aliB was kindly provided by C. van der Gast, Nijmengen, Netherland. AliB specific primers
(aliB_1276, aliB_1277) listed in S3 Table were used for amplification of the mutated aliB gene
with Pfu polymerase. A 3.0 kb fragment was obtained and cloned into vector pSP72 digested
with PvuII. Recombinant E. coli DH5 harbouring the corresponding recombinant plasmid
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were selected on LB medium supplemented with chloramphenicol. The isolated recombinant
plasmid (pSP1037) was transformed into our D39 strain by adding competence stimulating
peptide-1 at a final concentration of 0.04 μg as described earlier [70], and mutants were
selected on blood agar plates supplemented with chloramphenicol. Gene replacement by chro-
mosomal integration was verified by analytical PCR using total DNA from the pneumococcal
mutant and primer pair aliB_1276/aliB_1277 (S1A and S1B Fig).
For mutagenesis of comDE a designed PCR product containing an aphA3 gene cassette
instead of comDE genes was kindly provided by Reinhold Brückner, University of Kaiserslau-
tern. The construct was generated by overlap PCR. PCR reactions were carried out to amplify
upstream and downstream region of comDE with primers containing additional sequences of
a kanamycin gene. Primer combination of ComC_fwd/comD_kan_rev2 were used to amplify
837 bp fragment upstream of comDE and primer combination ComE_kan_fwd2/comE_rev to
amplify 831 bp downstream of comE. Total DNA from strain R6 as template was added. The
aphA3 cassette (0.9 kb) encoding kanamycin resistance was amplified with primer pair
ComD_kan_fwd2/ComE_kan_rev2 with complementary sequence of comD or comE and RK4
DNA (ccnD::aphA3) as template [76]. The resulting PCR fragments were separated and puri-
fied from agarose gels with gel DNA recovery kit (Zymo Research). All three DNA fragments
were used in an overlap PCR reaction with primer combination ComC_fwd/ComE_rev for
the generation of the 2,657 bp mutant construct. Reamplification was carried out with primer
pair comDE_1224/comDE_1225 and mutant construct as template to amplify a 2.1 kb frag-
ment (comDE::aphA3), which was transformed into D39 and D39ΔaliB for the generation of
comDE deletion mutants. Recombinant clones harbouring the comDE deletion were selected
on blood agar containing kanamycin (300 μg/ml) and replacement was verified by analytical
PCR using the primer combination comDE_1224/comDE_1225 (S1 Fig). The deficiency in
AliB expression was also confirmed by immunoblot analysis with anti-AliB serum (S1 Fig).
Heterologous expression of AliB, protein purification, and generation of
polyclonal anti-AliB and anti-pneumolysin antibodies for immunoblotting
The aliB gene (SPD_1357) was amplified with primers aliB_1288/aliB_1277 (nucleotide posi-
tion 76–1959). Primers contained the NheI and SacI site to clone the digested PCR product
into similarly digested vector pTP1 [70]. This generates an N-terminal His6-tag fusion to AliB.
The resulting plasmid pET1033 was transformed into E. coli BL21(DE3) for heterologous pro-
tein expression of AliB. Recombinant clones were cultivated in LB medium with kanamycin at
30˚C until reaching an OD600nm of 0.6, and expression was induced with 1 mM IPTG (isopro-
pyl-b-D-1-thiogalactopyranoside) for 3 h. Bacteria were lysed by sonification (3 times each 30
sec at 75%), and cytoplasmic protein extract was received after centrifugation at 16,000 x g for
20 min at 4˚C. Protein extract was loaded on His Trap HP Ni-NTA column (1 ml; GE Health-
care), and purification of His6-AliB was performed with increasing imidazole concentration
(linear range between 0–500 mM) using an Äktapurifier liquid chromatography system (GE
Healthcare) according to the instructions of the supplier. The His6-tag was removed by TEV
protease cleavage overnight in 100 mM NaCl, 50 mM NaH2PO4, pH 7.4 at 4˚C as described
[70], and recombinant purified rAliB was collected from the flow through by a second affinity
chromatography. The purity of rAliB was analysed by SDS-PAGE and staining of the gel with
Coomassie brilliant blue, and protein concentration was determined with Bradford reagent
according to the manufacturer’s description (BioRad).
Purified His6-tagged AliB (rAliB) and purified strep-tagged pneumolysin (rPLY) were used
to raise polyclonal antibodies in 6–8 weeks old female CD-1 mice by a routine immunization
protocol. Briefly, 20 μg of purified rAliB or rPLY in 100 μl PBS buffer was intraperitoneally
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injected into the mice with an equal volume of incomplete Freund’s adjuvant (Sigma Aldrich).
After two weeks same amount was injected for boosting. This was repeated one more time.
After 6 weeks mice were sacrificed and serum was collected. Specificity of polyclonal anti-AliB
or anti-pneumolysin antibodies was tested in immune blots. Thus, pneumococcal crude
extract or purified rAliB was separated by SDS-PAGE and transferred onto nitrocellulose by
semidry blotting (BIORAD). Membrane was blocked with 5% skim milk in TBS-Tween buffer
(0.2 M NaCl, 50 mM TRIS, 0.5% Tween20, pH7.4). Alkaline-phosphatase goat anti mouse IgG
(1:5000) (Abcam) was used as secondary antibody for the detection anti-AliB serum (1:1000)
or anti-Ply (1:500). Signals were visualized with NBT/BCIP color development substrate for
alkaline phosphatase activity. Detection of DacB (L,D-carboxypeptidase) or ArcB (ornithine
carbamoyltransferase) was conducted with specific mouse anti-DacB or anti-ArcB polyclonal
serum [33, 77] as loading control.
Determination of the capsular polysaccharide amount by flow cytometry
Flow cytometry was applied to investigate the amount of capsular polysaccharide of S. pneu-
moniae D39 serotype 2. In principle, the flow cytometric analysis was carried out as described
recently [70]. Briefly, pneumococci cultured in liquid media (CDM) were harvested, and 1 x
108 bacteria were incubated with an anti-serotype 2 specific antiserum (Statens Serum Insti-
tute, Denmark) (1:500 dilution in PBS) for 30 min at 4˚C. Samples were then washed twice
with PBS/0.5% FCS and stained with secondary goat anti-rabbit IgG coupled Alexa-Fluor-488
(Abcam). After 30 min incubation at 4˚C bacteria were washed twice with PBS/0.5% and then
fixed with 2% formaldehyde. Flow cytometry was conducted with a FACSCalibur™ (BD Biosci-
ences, Heidelberg, Germany), and the CellQuestPro Software 6.0. (BD Biosciences) was used
for data acquisition while analysis of the data was performed with the software WinMDI 2.9.
The forward scatter (FLI-H) in the histograms (Fig 5B) demonstrated the increase in fluores-
cence intensity.
Determination of pneumolysin activity by lysis of erythrocytes
S. pneumoniae D39 and corresponding aliB, comDE or double mutants were cultured in THY
medium. Samples were taken at OD600nm of 0.8 and 1.2, centrifuged at 3,000 g for 10 min at
RT. The supernatant was collected and stored at 4˚C. Fresh human erythrocytes solubilized in
PBS buffer were used. The activity assay was performed as described by Benton et al., with
minor modifications. A microtiter plate (Nunc) was loaded with 0.1 ml lysis buffer (10 mM
DTT, 0.1% BSA in BPS buffer, pH 7.4) 0.05 ml of the corresponding culture supernatant, and
0.05 ml of the erythrocyte solution. The plate was incubated for 45 min at 37˚C. As a control
only buffer and erythrocyte solution was loaded. After centrifugation at 530 g at RT for 10 min
the microtiter plate was analysed. Pneumolysin activity was detected by haemolysis and no
erythrocyte sediment was obtained.
Statistical analysis
All data are reported as mean ± SD unless otherwise noted. Results were statistically analysed
using the unpaired two-tailed Student´s test. Kaplan-Meier survival curves were compared by
the log-rank test. P-values for bioluminescence measurements were calculated using the
unpaired, one-tailed t-test for differences between groups, while differences of one group
between days were analysed by paired t-test. For animal experiments, samples were conducted
under the supervision of a professional statistician during the planning period of the project.
The proteomics study was considered as an explorative descriptive investigation. Based on the
documented research experience in this field, a sample size of 5 was judged adequate for this
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approach. The virulence study was considered as a comparative experiment. Sample size calcu-
lations were done with the primary outcome parameters clinical score and the CSF leukocyte
counts. The calculations were based on a multiple group comparison design using an analysis
of variance (ANOVA) model, assuming 80% power, α of 0.05, and two-tailed test for statistical
significance. The sample size per group needed to detect a significant difference was found to
be 8 for the mutant groups and 13 for the wild type control group. Methods for statistical anal-
ysis of in vivo data comprised the Shapiro-Wilk normality test, the Brown–Forsythe equality of
variance test, and One-Way ANOVA analysis with Tukey post-hoc test. A P-value <0.05 was
considered to be statistically significant.
Accession numbers
Raw data and proteomics data can be accessed via the PeptideAtlas (http://www.peptideatlas.
org/).
Supporting information
S1 Fig. Generation and verification of comDE and aliB mutants in D39. (A) Insertion-dele-
tion mutagenesis was carried out to inactivate aliB and comDE. AliB was replaced by the cat
gene expressing chloramphenicol resistance and comDE was replaced by aphA3 encoding
kanamycin resistance. (B) Molecular analysis of comDE, aliB and comDE/aliB mutants by
PCR. Total DNA from wild-type and corresponding mutants were used as template with
primer pair aliB_1276/aliB_1277 or primer combination comDE_1224/comDE_1225 to dem-
onstrate aliB (left panel) and comDE (right panel) inactivation. (C) Analysis of AliB expression
in D39 wild-type and mutants. Immunoblotting was performed with polyclonal anti-AliB
serum and secondary goat anti-mouse IgG conjugated with alkaline phosphatase. Detection of
AliB or homologs was done with NBT/BCIP for color development. Anti-ArcB antibodies
were choosen for ArcB detection as loading control. Due to high similarity of AmiA, AliA and
AliB all of these proteins were detected with anti-AliB polyclonal antibodies.
(TIF)
S2 Fig. Growth of pneumococcal mutants. Growth of pneumococcal wild-type and isogenic
mutants in chemically-defined medium (CDM = RPMImodi) or in CSF from humans. Deter-
mined growth rates in CDM are: D39 (μ = 0.65 h-1), ΔaliB-mutant (μ = 0.65 h-1), ΔcomDE-
mutant (μ = 0.66 h-1), and ΔaliBΔcomDE-mutant (μ = 0.69h-1). In CSF the following growth
rates were estimated: D39 (μ = 0.54 h-1), ΔaliB-mutant (μ = 0.49 h-1), ΔcomDE-mutant (μ =
0.48 h-1), and ΔaliBΔcomDE-mutant (μ = 0.50 h-1).
(TIF)
S3 Fig. Lack of ComDE and/or AliB was associated with increased motor activity and
reduced weight loss in murine pneumococcal meningitis. Pneumococcal meningitis was
induced by intracisternal injection of wild type S. pneumoniae D39 (n = 13) or its isogenic
ComDE-deficient, AliB-deficient- or AliB-ComDE-double-deficient mutants (each mutant
n = 8). Eighteen hours later, motor activity (A) and body weight (B) were determined using an
open field test and a precision scale, respectively. (A) Mice infected with the single or double
mutants showed significant increased motor activity when compared to D39 infected mice.
(B) Mice infected with the double mutant also exhibited less pronounced weight loss than
those infected with D39. In negative controls (mice injected i.c. with PBS instead of S. pneumo-
niae; n = 8), motor activity was 45.0 ± 9.9 fields/min, whereas weight loss was 0.3 ± 0.4%. Data
are given as means ± SD. � P < 0.01, compared to mice infected with the D39 strain, using
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One-Way ANOVA and Tukey post-hoc test.
(TIF)
S1 Table. Proteins with differential abundance between S.p. D39ΔcomDE or S.p. D39ΔaliB
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